English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Cardiac lymphomas are extremely rare and have poor prognoses. Currently, there are no established guidelines for treatment and the main approaches include surgery, chemotherapy (CHT), possibly combined with radiotherapy (RT), and autologous stem cell transplantation (ASCT). RT’s role is controversial and is not considered a standard approach. We describe the case of a patient diagnosed with cardiac lymphoblastic B- cell lymphoma/ acute Lymphoblastic B-cell leukemia and successfully treated with a multimodality approach, including CHT, RT, and ASCT. In particular, the patient was referred to magnetic resonance-guided RT (MRgRT), currently the most advanced available technology in the RT field, which maximizes therapeutic efficacy by exploiting the best soft-tissue resolution of the magnetic resonance images and efficient gating protocols during treatment delivery.

Magnetic Resonance Guided Radiotherapy (MRgRT) For Cardiac Lymphomas: Case Report and New Perspectives